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Background: The SOS response including two main proteins LexA and RecA, maintains the integrity of
bacterial genomes after DNA damage due to metabolic or environmental assaults. Additionally, derepression
of LexA-regulated genes can result in mutations, genetic exchange and expression of virulence factors. Here
we describe the first comprehensive description of the in silico LexA regulon in Clostridium difficile, an important
human pathogen.
Results: We grouped thirty C. difficile strains from different ribotypes and toxinotypes into three clusters
according to lexA gene/protein variability. We applied in silico analysis coupled to surface plasmon resonance
spectroscopy (SPR) and determined 16 LexA binding sites in C. difficile. Our data indicate that strains within the
cluster, as defined by LexA variability, harbour several specific LexA regulon genes. In addition to core SOS
genes: lexA, recA, ruvCA and uvrBA, we identified a LexA binding site on the pathogenicity locus (PaLoc) and in
the putative promoter region of several genes involved in housekeeping, sporulation and antibiotic resistance.
Conclusions: Results presented here suggest that in C. difficile LexA is not merely a regulator of the DNA
damage response genes but also controls the expression of dozen genes involved in various other biological
functions. Our in vitro results indicate that in C. difficile inactivation of LexA repressor depends on repressor`s
dissociation from the operators. We report that the repressor`s dissociation rates from operators differentiate,
thus the determined LexA-DNA dissociation constants imply on the timing of SOS gene expression in C. difficile.
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LexA repressorBackground
Organisms have evolved gene regulatory systems to main-
tain their genetic integrity. The SOS regulatory network
is a paradigm for bacterial response to DNA damage
which is controlled by a global transcriptional repressor
LexA and an inducer, the recombinase protein RecA. Dur-
ing normal bacterial growth, LexA binds to DNA recogni-
tion sequences (operator) positioned near or overlapping
the promoter elements of the SOS genes and occludes
RNA polymerase, preventing SOS gene transcription.
Upon DNA damage, RecA polymerizes on single-stranded
DNA (ssDNA) formed at sites of DNA damage, becomes* Correspondence: Matej.Butala@bf.uni-lj.si
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unless otherwise stated.activated (RecA*) and facilitates self-cleavage of LexA
resulting in coordinated expression of SOS genes [1].
The SOS system was found in almost all eubacterial
groups [2]. It was suggested that the LexA operator
spread from Gram positive bacteria into Gram negative
bacteria, which indicates on the evolutionary origin of
the LexA protein [3]. In Escherichia coli, the consensus
operator sequence (SOS box) has been identified as 5′-
CTGTN8ACAG-3′ [4] and in the spore former Bacillus
subtilis 5′-GAACN4GTTC-3′ [5]. The SOS response
comprises a variety of physiological processes, not solely
involved in the upkeep of the bacterial genome. LexA re-
presses synthesis of toxins [6,7] and antibiotic resistance
determinants [8], controls integron cassette recombin-
ation [9] and lateral transfer of virulence factor genes
[10], as well as drug resistance genes [11].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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among species. B. subtilis LexA controls a regulon of
over 60 genes [12] with only eight of these genes having
orthologs in E. coli. Those genes play roles in SOS regu-
lation and excision, recombinational and error-prone
DNA repair [5].
C. difficile is a human pathogen causing a spectrum of
intestinal diseases ranging from mild diarrhoea associated
with antibiotic treatment to, in more severe cases, pseudo-
membraneous colitis [13]. Despite extensive research fo-
cused on the bacterium, knowledge regarding its SOS
system is scarce [14]. Among other clostridia species,
binding sites for LexA were identified in C. acetobutylicum
and C. perfringens and resemble Bacillus LexA operator
sequences [15,16]. As a suitable target site for LexA is suf-
ficient for binding in vivo [4], we used a robust in silico ap-
proach [17] and predicted the LexA-regulated genes of
several C. difficile strains. In addition, surface plasmon res-
onance (SPR) was used to confirm the interactions of
LexA with regions defined in in silico experiments.
Results and discussion
Variability of the lexA gene in C. difficile
C. difficile has been described as a bacterium with highly
mosaic genetic composition and multiple attempts have
been made to distinguish between various strains and to
correlate them with virulence [18]. We first analysed the
variability of the repressor LexA encoding gene sequence
among various C. difficile ribotypes (groups character-
ized by differences in intergenic regions of RNA operon
and used worldwide for C. difficile typing) and toxino-
types (characterized by differences in toxin A and B cod-
ing region inside the pathogenicity locus called PaLoc)
(Additional file 1: Table S1) [19]. Analysis revealed 17
single nucleotide polymorphisms (SNPs) in the lexA
gene of 63C. difficile sequences among which four SNPs
resulted in missense mutations but none of the muta-
tions modified amino acids in the cleavage or active
sites of LexA (Figure 1). Our analysis grouped the investi-
gated strains into three clusters according to the C. difficile
LexA (Figure 2). Cluster I encompassed 3 non-toxinogenic
strains and strains of toxinotype 0; Cluster II encompassed
strains of toxinotypes III, VIII, IX, and X and finally, Clus-
ter III with the highest number of SNPs, was mostly com-
posed of toxinotype V strains. Ribotypes for the above
stated toxinotypes can be found in the Additional file 1:
Table S1. Previous results showed that strains belonging to
the epidemic ribotype 027 form a genome wide clade
[20,21], typically characterised as the toxinotype III (North
American pulsed field gel electrophoresis type 1 - NAP1,
REA group BI). Interestingly, ribotypes 016, 019, 036, 075,
111, 122, 153, 156, 176, 208 and 273 are closely related to
ribotype 027 by comparative genomics [20,21], and those
ribotypes were found to encompass the lexA cluster II.Comparative phylogenomics along with MLST (multi-
locus sequence typing) and whole genome sequecing
has shown that ribotype 078 lineage is different than
other C. difficile lineages [22]. Moreover PCR ribotype
078 forms a phylogenetically coherent group with ribo-
types 033, 045, 066, 078, 126 and 127 [23] – which en-
compasses lexA cluster III. Genetically distinct strains
that belong to ribotypes 078 (V) and 126 (V) clustered
together showing the highest number of SNPs in the
lexA gene. The phylogenetic tree based on LexA vari-
ability reflects similarities to genetic lineages based on
ribotype patterns and comparative genomics analysis.
In silico screening for the LexA-regulated genes in C. difficile
To obtain insight into the LexA regulon genes, we per-
formed in silico genome-wide prediction of LexA bind-
ing sites within promoter regions of C. difficile. Using
the xFiToM software [24], we screened genomes of
thirty C. difficile strains (Additional file 1: Table S1) for
the C. acetobutylicum and C. perfringens consensus op-
erator sequence of LexA [15,16], allowing for two mis-
matches in one of the two half sites positioned within
350 bp upstream to 35 bp downstream of a protein cod-
ing sequence. Among the thirty genomes, the search
yielded at least one putative operator sequence upstream
of more than 30 genes involved in a variety of biological
processes e.g. DNA repair, transport, virulence and anti-
biotic resistance (Table 1).
Subsequently, we purified C. difficile LexA and RecA
proteins with an N-terminal hexa-histidine tag (Additional
file 2: Figure S1) as described for E. coli orthologs [25].
SPR analysis was performed to validate the in silico data
and determine the LexA-operator interactions in vitro in
real time. Most of the interaction sites were found in puta-
tive promoter regions of “common” putative SOS genes
for the majority of the genomes tested and of putative
LexA regulon genes encoding unusual SOS proteins. Out
of 20 DNA fragments tested, the repressor interacted with
16 targets (Figure 3A, Additional file 3: Table S2). We de-
termined interaction with operators in promoter regions
of the core SOS response genes: recA, lexA, the genes
of the uvrBA operon encoding for components of the
UvrABC endonuclease catalyzing nucleotide excision re-
pair and the ruvCA operon genes, encoding the nuclease
that resolves Holliday junction intermediates in genetic
recombination. In addition, LexA interacts with putative
promoter regions of genes involved in sporulation (sspB),
regulation of DnaA-dependent initiation of DNA repli-
cation (soj), several ABC transporters (potC, oppC,
MicroScope:CDR20291_2297) and for homologue of a
two-component system regulator of the vancomycin
resistance cluster (vanR). The LexA repressor was also
found to interact within PaLoc with operator identified
525 base pairs upstream of the toxin A gene (tcdA).
Figure 2 Dendrogram of the aminoacid sequence allignments of LexA derived from lexA genes of C. difficile strains. PCR ribotypes and
toxinotypes of the strains can be found in Additional file 1.
Figure 1 Variability of lexA gene in Clostridium difficile. Representation of the C. difficile 630 strain lexA nucleotide sequence in comparison to
repressor sequences of 62 other strains. Grey arrow denotes the nucleotide sequence of the CD630 lexA gene. Black arrows mark the position of
domains in LexA. The number of strains with specific SNP and the corresponding nucleotide/aminoacid change is marked above the arrow. The
ordinal number of nucleotides in lexA is presented below the arrow. The SNPs marked in blue encompass strains from cluster III, composed
mainly of strains belonging to the toxinotype V. The position of the cleavage site and the catalytic residues is marked in purple.
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Table 1 In silico predicted LexA binding sites in C. difficile ribotypes
Various toxinotypes Toxinotype V Toxinotype 0/nontoxinogenic
O33 O27 O75 O17 O78 126 OO9 OO1 O12 OO5 O87 O14 O53
Gene accession
number
GENE Product LexA BOX Distance 1 strain 8 strains 2 strains 1 strain 3 strains 2 strains 1 strain 3 strains 3 strains 3 strains 1 strain 1 strain 1 strain
CDR20291_1854 lexA Transcriptional regulator.
LexA repressor
GAAC....GTTT −51/-91 1 8 2 1 3 2 1 3 3 3 1 1 1
CDR20291_1169 recA Protein RecA
(Recombinase A)
GAAC....GTTT −39/-41 1 8 2 1 3 2 1 3 3 3 1 1 1
CDR20291_2696 ruvC Crossover junction
endodeoxyribonuclease
GAAC....GTTT −65 1 8 2 1 3 2 1 3 3 3 1 1 1
CDR20291_3234 uvrB Excinuclease ABC
subunit B
GAAC....GTTC −30 1 8 2 1 3 2 1 3 3 3 1 1 1
CDR20291_0487 rusA Putative RusA-like
endodeoxyribonuclease
GAAC....GTTT −122 1 4 1 1 3 2 NO NO 1 NO NO 1 NO
CDR20291_2024 trxB Thioredoxin reductase GAAC....GTTT −216 NO NO NO NO NO NO 1 NO NO NO NO NO NO
63q42v1_580022 rps3 Putative 30S ribosomal
protein S3
GAAC....GTTA −284 NG NG 1 NG NG NG NG 1 NG NG NG NO NO
CDR20291_3107 sspB Small. acid-soluble spore
protein beta
GAAC....GTTC 34 1 8 2 1 3 2 1 3 3 3 1 1 1
CDR20291_0784 oppC ABC-type transport
system. oligopeptide
GAAC…GTTT −285/-286 1 8 2 1 3 2 1 3 3 3 1 1 1
CDR20291_3532 soj Small walker A ATPase,
chromosome replication
GAAC....GTTT −226 NO 8 2 1 NO NO 1 3 3 3 NO 1 1
CDR20291_2297 Putative multidrug efflux
pump
GAAC…TTTT −138 1 8 2 1 3 2 1 3 3 3 1 1 1
63q42v1_310170 ABC-type multidrug-family GAAC....CTTT −154 1 8 2 1 3 2 1 3 3 3 1 1 1
CDR20291_3125 vanR Regulatory protein vanR GAAC....ATTT −222 NO 8 2 NO NO NO NO NO NO NO NO NO NO
CDR20291_0083 rplR 50S ribosomal protein L18 GAAC....GTTT −261/-262 1 8 2 1 3 2 1 3 3 3 1 1 1
CDR20291_0060 rpoB DNA-directed RNA
polymerase subunit β
GAAC…GTTT −42/-43 1 8 2 1 3 2 1 3 3 3 1 1 1
CDR20291_1619 Putative transcriptional
regulator
GAAC…GTTT 30/31 1 8 2 1 3 2 1 3 3 3 1 1 1
63q42v1_570034 Helix-turn-helix domain
protein
GAAC…CTTT −97 NG 3 NG 1 NG NG NG 1 NG 1 NG NG NG
CDR20291_0882 potC ABC-type transport system. GAAC…GTTC −207 1 8 2 1 3 2 1 3 3 3 1 1 1
CDR20291_0584 tcdA Toxin A GAAC....GTTT −525 NG 8 2 NG 3 2 NG 3 3 3 1 1 1
CDR20291_3466 Putative cell wall hydrolase GAAC…GTTT −68 NO 8 NG NO NO NO NO NO NO NO NO NO NO
CDR20291_2689 Putative membrane
protein
GAAC....GTTT −111 NO 7 2 1 NO NO 1 3 3 3 1 1 1
CDR20291_1611 moaB Molybdenum cofactor
biosynthesis
GAAC…GTTT −6 NO 8 2 NO NO NO 1 3 NO 3 1 1 NO
CDR20291_2775 celG Cellobiose-phosphate
degrading protein



















Table 1 In silico predicted LexA binding sites in C. difficile ribotypes (Continued)
CDR20291_3372 phnH Phosphonate
metabolism protein
GAAC....CTTT −34 NG 8 2 1 NG NG 1 3 3 3 1 1 1
CDR20291_1600 thiC Thiamine biosynthesis
protein ThiC
GAAC....ATTT −175 1 NO NO NO 3 2 NO NO NO NO NO NO NO
CDR20291_1940 N-carbamoyl-L-amino
acid hydrolase




GAAC....GTTT −466 1 8 2 1 3 2 1 3 3 3 1 1 1
NAP07v1_640016 Two-component
sensor histidine kinase
GAAC....GTTT −217 NO 8 NO NO NO NO NO NO NO NO NO NO NO
CDR20291_0331 cbiQ Cobalt transport protein GAAC....GTTT −122 1 8 2 1 3 2 1 3 3 3 1 1 1
CDR20291_2597 Putative oxidoreductase GAAC....CTTC 2 1 8 2 1 3 2 1 3 3 3 1 1 1
NAP07v1_470051 aroF P-2-dehydro-3-
deoxyheptonate aldolase
GAAC....CTTT −225 1 NO NO NO 3 2 NO NO NO NO NO NO NO
97b34v1_600001 Transposase GAAC....GTTT −217 NO 8 NO NO NO NO NO NO NO NO NO NO NO
CDE15v2_1270013 Putative cI repressor GAAC....GTTC −67 NG NG NG NG NG NG NG NG NG NO 1 NO NG
63q42v1_370450 Extrachromosomal
origin protein
GAAC…GTTT 10 NG NG NG NG NG NG 1 3 3 3 1 1 1
CDR20291_1803 vexP ABC transporter. ATP-
binding/permease
GTTC....TTTT −85 NO 8 2 1 NO NO NO 1 2 NO NO NO 1
97b34v1_250108 ABC-type transport
system. sugar-family
GAAC…GTTC −267 NG 8 2 NG NG NG NG NG NG NG NG NG NG
Sequences of putative LexA operators and their positions (according to the start of the gene coding region). Numbers denote strains with the operator identified. NO marks the gene that was identified in the strain



















Figure 3 C. difficile LexA regulon genes. (A) SPR sensorgrams of the binding of C. difficile LexA with in silico predicted target DNA sites.
Selection of LexA target genes determined by in silico and analysed by SPR. LexA (20 nM) was injected for 60 s across the chip-immobilized DNA
fragments containing either of the putative operators and dissociation was followed for 540 s. The representative sensorgrams are shown and the
dissociation constants presented as average values of triplicate experiments presented with standard deviation. By n.d. we mark if dissociation rate
constant was not determined and the response units are marked by RU. With the MEME tool determined motifs for the target DNA sites found in
promoter regions of the genes higher affinity CDR20291_2056, lexA, uvrB, recA, sspB, ruvC, CDR20291_2689, oppC, tcdA, 97b34v1_250108, showing
high affinity for LexA (B) or of the genes rplR, rpoB, soj, potC, vanR, CDR20291_2297 to which LexA does not bind stably (C).
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is controlled in response to several environmental sig-
nals mediated by pleiotropic regulators (CcpA, CodY,
SigD and SigH [26]), the possible regulation through
the SOS system sheds new light on this issue. Further-
more, the subinhibitory concentration of SOS-inducing
antibiotic ciprofloxacin was recently shown to increase
the Toxin A gene expression in C. difficile [27]. Our
SPR analysis revealed that also housekeeping genes re-
quired for ribosome function (rplR) and β subunit RNA
polymerase (rpoB) belong to the LexA regulon, a fea-
ture of the SOS network not yet observed in bacteria.
Thus, blockage of LexA self-cleavage could impede piv-
otal functions in C. difficile and this might provide a
new approach to treat C. difficile infections. Moreover,
although putative SOS genes are present in most of the
analysed genomes, several of these genes encoding for
putative cell wall hydrolase, transposase and for two
component sensor histidine kinase seem to be regulated
by LexA only in the 027 ribotype strains (Table 1). The
in silico analysis showed operators in front of several
genes upregulated exclusively in ribotype 075 and 027
(celG, vanR, ABC-type transport system). Furthermore,
among the analysed genomes, exclusively in the closely
related ribotypes 078, 126 and 033, the LexA target site
was not found in front of the soj (regulation of DNA
replication) and the phnH (phosphonate metabolism
protein). Thus the mode of SOS regulation might be re-
lated to phylogenetic lineages.Cross-reaction of SOS system components in E. coli and C.
difficile
Induction of SOS gene expression is synchronized and
the level, timing and duration of expression of the indi-
vidual LexA regulon genes differs significantly (1). In
E. coli, LexA bound to target DNA cannot interact with
RecA* and only unbound repressor is proteolytically
inactivated [25]. Thus the rate of LexA dissociation from
operators controls the precise timing of SOS gene ex-
pression following induction. Consequently genes with
lower affinity LexA target sites are expressed prior to
genes with high affinity operators [1,5]. To follow up on
these results, we used SPR to study interaction of the
chip-immobilized C. difficile RecA* with LexA interacting
with either specific or non-specific DNA. We showed that
as in E. coli, the C. difficile LexA repressor interaction with
RecA* is prevented by binding to specific DNA targets
(Figure 4). In addition, we showed that the key SOS
players of E. coli and C. difficile can cross-react in vitro
(Figure 4). Hence, our data indicated that the mode of
regulation of the C. difficile SOS response resembles the
one described for E. coli. Nevertheless, in contrast to the
E. coli SOS system, we observed among the investigated
C. difficile genes, a slowest LexA dissociation from opera-
tors of the core SOS genes, recA, lexA and uvrB (Figure 3A
and B, Table 2), implying that these are the last genes up-
regulated upon SOS induction. For instance, LexA dissoci-
ation from the E. coli recA operator is more than 20-times
faster than from C. difficile with regard to the dissociation
Figure 4 Specific DNA precludes C. difficile RecA*-LexA interaction. Interaction of C. difficile LexA repressor (2.6 μM) incubated with specific,
22-bp recA operator (A) or with non-specific DNA fragment, recA operator with modified six nucleotides (B), with the chip-immobilized C. difficile
RecA* (~2000 response units). The used DNA interacting with repressor was in 1.4 μM (black line), 2.7 μM (red line), 4.0 μM (green line), 5.4 μM
(blue line), 8.1 μM (pink line) concentration. The cyan line presents sensorgram of the free DNA at 8.1 μM concentration interacting with the
RecA*. (C) In vitro repressor cleavage pattern exhibits that purified E. coli and C. difficile key SOS players can cross-react. C. difficile proteins are
marked as RecA* (CD), LexA (CD) and E. coli proteins as RecA* (EC) and LexA (EC), respectively. Time course (min) of either C. difficile or E. coli
RecA*-induced inactivation of LexA (CD) or LexA (EC) repressor. Quantification of LexA is presented on the gel above the respective band as the
ratio (%) of the protein density value of the initial sample (0 min) relative to the density value obtained from the proteins after indicated time
points after addition of RecA*, shown with standard deviation.
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s−1, respectively.
We propose that in C. difficile, strong repression of
core SOS genes affects the magnitude of the system`s
induction. Thus, the low association and non-stable
LexA binding to putative regulatory regions of genes en-
coding the RNA polymerase β subunit (rpoB), 50S ribo-
somal protein (rplR), spermidine/putrescine permease
(potC), vancomycin response regulator (vanR) and putative
multidrug-efflux-pump [MicroScope: CDR20291_2297], in-
dicates that LexA contributes to fine-tuning of expression
of these genes independently of substantial recA induction
(Figure 3).
The paradigm of the SOS system is that DNA repair
genes are rapidly induced in the SOS response to deal
with DNA lesions [1,2,28]. However, comparison of in-
duction of LexA regulon genes in B. subtilis and E. coli
in response to double-strand breaks reveals diversity
[29]. After DNA damage, the velocity of assembly of
RecA* is similar but in contrast to E. coli, a limited set
of LexA-regulated genes are induced early in the re-
sponse in B. subtilis. Our in vitro results suggest thatalso in C. difficile, induction of the LexA-regulated DNA
repair genes might be induced later in the SOS response
as the core SOS gene promoter regions harbour high af-
finity LexA targets. According to the differences in
LexA-operator affinities we predict that upon DNA
damage, various biological processes will be derepressed
without induction of the SOS DNA repair.
Conclusions
We have generated maps of LexA target sites within the
genomes of C. difficile strains. We predict that SOS
functions in C. difficile are not solely involved in the
DNA repair but are probably linked to other biological
functions (virulence factors, sporulation,…). As C. diffi-
cile infection is a growing problem in healthcare facilities
and community patients, further characterisation of the
LexA-regulon could provide key insights into pathogen-
esis. Our data suggest that molecules targeting key SOS
proteins could block several houskeeping functions and
could provide next generation of C. difficile antibiotics.
Furthermore, the defined differences in lexA gene group
C. difficile strains into three clusters which correlated
Table 2 Target DNA sequences of the putative SOS genes of the R20291 strain used for the SPR analysis









Protein RecA (Recombinase A) GAGAACAAATGTTTGT −39/-41
ruvC DNA repair Crossover junction
endodeoxyribonuclease
TAGAACATAAGTTTTT −65
uvrB DNA repair Excinuclease ABC subunit B AGGAACTAATGTTCGA −30
sspB Spores Small. acid-soluble spore protein beta CAGAACAGTAGTTCCA 34
oppC Spores/ABC transporter ABC-type transport system.
oligopeptide-family
TAGAACATAAAAATTT −285/-286
soj Regulation of DNA
replication
protein Soj TTGAACTTTAGTTTCT −226
CDR20291_2297 Antibiotics Putative multidrug efflux pump AAGAACATCTGAAAAG −138
vanR Antibiotics Response regulator VanR CAGAACTATTATTTTA −222
rplR DNA/RNA 50S ribosomal protein L18 ATGAACTTAGGTTTCT −261/-262
rpoB DNA/RNA DNA-directed RNA polymerase subunit
beta
ATGAACTATTGTTTTA −42/-43
potC Biofilm ABC-type transport system. spermidine/
putrescine
TGGAACTTTGGTTCAG −207
tcdA Toxicity Toxin A GTGAACCAATGTTTGA −525
CDR20291_2689 Cell wall/membrane Putative membrane protein TGGAACTTTAGTTCTA −111
CDR20291_2056 Signalling Putative endonuclease/exonuclease/
phosphatase
AAAAACACCCGTTCTGCAAACATTCGTTCTG −466
NAP07v1_640016 Signalling/Chemotaxis Two-component sensor histidine
kinase
GAGAACCTGTGTTTTT −217




vexP ABC transporter ABC transporter. ATP-binding/permease
protein
AAGTTCAAATTTTTGA −85
97b34v1_250108 ABC transporter ABC-type transport system sugar-family AAGAACTAAAGTTCCT −267
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The C. difficile genomes were obtained from an opened
access NCBI database [30] and an undisclosed access to
MicroScope platform [31]. The strains used for amplifica-
tion with PCR and sequencing belong to the strain collec-
tion of the Institute of Public Health Maribor. The list of
strains used for analysis of the LexA variability and regu-
lon is presented in the Additional file 1: Table S1.
Variability of lexA gene
Variability of lexA in C. difficile was compared by ana-
lysis of alignment and phylogenetic trees of nucleotides
and amino acid sequences performed with Vector NTI(Invitrogen) and with the interactive viewer for phylo-
genetic trees: Dendroscope [32]. Sixty three sequences
were analysed in total (NCBI – 9 strains, MicroScope –
44 strains, PCR product of in-house strains – 10).
Strains CD196, R20291 and 630 were obtained from
both databases. List of strains used for lexA gene vari-
ability can be found in Additional file 1: Table S1.
In silico determination of the C. difficile SOS regulon
The search for LexA binding sites was performed for 30
genomes (Additional file 1: Table S1). The number of
strains covering ribotypes was as follows: ribotype 027 –
eight strains; ribotypes: 078, 001, 005 and 012 - three
strains from each; ribotypes 075 and 126 two strains from
each and one genome from each ribotypes 017, 087, 014,
053. The analysis was performed with xFiToM software
[24]. The searched motifs, based on C. acetobutylicum
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nnnnGTTT, GAACnnnnGTTC, GAACnnnnnTTT, GA
ACnnnnnTTC. The default options were used with the
limitation to 350 base pairs upstream to 35 bp downstream
of a protein coding sequence. An exception was the pro-
moter region of the putative endonuclease/exonuclease/
phosphatase (MicroScope: CDR20291_2056) where we
found 2 operators positioned approximately 460 upstream
of the coding sequence and hence, we included the targets
in the analysis. The results were subjected to manual check
by extraction of gene sequences along with 1000 base pairs
upstream and downstream followed by alignment and re-
search of the binding sites.
Cloning, expression and isolation of recombinant C.
difficile LexA and RecA protein
The C. difficile 630 chromosomal DNA was extracted by
the Genomic DNA purification kit (Thermo Scientific) ac-
cording to the manufacturer`s instructions. The lexA and
recA genes were amplified by PCR from the chromosomal
DNA using specific primers (DinR_U 5′-GCGCGGATCC
AGTGATGTTATGTATTTAGATC-3′ - DinR_D 5′-CGC
ACGCGTCTATTTAATAACTCTAAATAC-3′) and (Rec
A_U 5′-GCGCGGATCCAGTGTAGATCAAGAAAAAT
TAAAAG-3′ - RecA_D 5′-CGCACGCGTTTATTCTTC
TACAATTTCTTTTG-3′), respectively. The PCR prod-
ucts were then purified and cut with BamHI and MluI
and cloned into pET8c vector digested by the same en-
zyme to create plasmids pDinRCD and pRecACD for ex-
pression of proteins fusion with N-terminal His6 tag.
Large-scale expression of proteins was performed in the
E. coli BL21 (DE3) strain and purified from the bacterial
cytoplasm by Ni-NTA affinity chromatography as described
for the E. coli key SOS proteins [25]. PD10 desalting
columns (GE Healthcare) were used for exchange of the
buffer. The proteins were stored at −80°C in 20 mM
NaH2PO4 (pH 7.4), 0.2 mM NaCl. Protein concentrations
were determined using NanoDrop1000 (Thermo Scien-
tific) and extinction coefficients at 280 nm of 7450
M−1 cm−1 for recombinant LexA and 16055 M−1 cm−1 for
recombinant RecA.
Surface plasmon resonance assays
C. difficile LexA-operator measurements were per-
formed on a Biacore T100 (GE Healthcare) at 25°C as
described [6]. The 3′-biotynilated 5-CGCTCGAGTA
GTAAC-TEG-Bio-3′primer was immobilized on the
flow cell 2 (Fc2) of the streptavidin sensor chip (GE
Healthcare) in SPR buffer containing 20 mM Tris–HCl
(pH 7.4), 140 mM NaCl, 0.005% surfactant P20 (GE
Healthcare). To prepare double stranded DNA (dsDNA)
fragments with the predicted C. difficile LexA operators,
complementary pairs of primers presented in Additional
file 3: Table S2 were dissolved in 20 mM NaH2PO4(pH 7.4), 0.14 M NaCl and mixed in 1:1.5 (mol : mol) ra-
tio for the longer to shorter primer, respectively. Primers
were annealed in temperature gradient from 95°C to 4°C
(~ 1.5 h) in PCR machine (Eppendorf). So prepared
DNA fragments were approximately 22 bp duplex DNAs
with 15-nucleotide overhangs complementary to the
chip-immobilized primer. Approximately 44 response
units of either DNA fragment were hybridised at
2 μl min−1 to the Fc2. The interaction of C. difficile
LexA with the chip-immobilized DNAs was analysed by
injecting repressor in SPR buffer in 20 nM concentration
across the chip surface at 100 μl min−1 for a minute and
dissociation was followed for 9 minutes. The regener-
ation of the surface was achieved injecting 12 s pulse of
50 mM NaOH at 100 μl min−1. The experiments were
performed in triplicates and the representative sensor-
grams are shown. Data were fitted to a 1:1 binding
model to obtain the dissociation rates constants. Pro-
gram MEME was used to determine LexA binding mo-
tifs [33].
SPR C. difficile RecA*-LexA interaction measurements
were performed on a Biacore X (GE Healthcare) at 25°C
as described to study the interaction among the key
E. coli SOS proteins [25]. Experiments were performed
in SPR_2 buffer (20 mM NaH2PO4 (pH 7.4), 150 mM
NaCl, 2 mM MgCl2, 1 mM DTT, 1 mM ATP (Sigma Al-
drich), 0.005% surfactant P20 (GE Healthcare). C. diffcile
LexA repressor (2.6 μM), interacting with either the
22 bp recA operator DNA fragment or with the 22 bp
non-specific DNA fragment derived from the recA oper-
ator, was passed over the sensor chip with immobilized
RecA* (~2000 response units). LexA specific DNA (recA
operator) or non-specific DNA, with 6 nucleotide chan-
ged in comparison to the specific DNA, was prepared by




respectively. The RecA*-LexA interaction was assayed
at 10 μl/min for 60 s and the dissociation followed for
60 s. The sensor chip was regenerated as described [25].
Repressor cleavage assay
Activation of either E. coli or C. difficile RecA (10 μM)
nucleoprotein filament was performed on ice for 2 h as
described [34]. RecA*-stimulated (~2 μM) cleavage of
LexA were performed in 20 mM Tris, pH 7.4, 5 mM
MgCl2, 1 mM ATP-γ-S (Sigma), and 1 mM DTT as de-
scribed [25]. Samples were resolved on 12% SDS PAGE
gels in MOPS running buffer (Invitrogen) and stained by
Page blue protein stain (Thermo Scientific). The re-
solved bands were quantified using a G:Box (Syngene).
The integrated optical densities of the LexA monomers
were determined. The LexA levels throughout the time
Walter et al. BMC Microbiology 2014, 14:88 Page 10 of 11
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the density value for the sample at time indicated as
0 min relative to the density value obtained from the
samples obtained later in the LexA cleavage reaction.
The experiments were performed two times and repre-
sentative gels are shown.
Additional files
Additional file 1: Table S1. List of genomes used for analysis of SOS
regulon and LexA variability. The names of the strains used for SOS
regulon analysis are additionally bolded.
Additional file 2: Figure S1. Comassie stained C. difficile (CD) LexA and
RecA proteins and the LexA protein from Escherichia coli (EC). Proteins
used in the study were more than 95% pure. Approximately 5 μg of each
protein was loaded on the SDS-PAGE gel.
Additional file 3: Table S2. Pairs of primers used to construct double
stranded DNAs harbouring predicted LexA target sites. Putative LexA
operators are underlined.
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